Effect of Pamidronate on Bone Loss After Kidney Transplantation: A Randomized Trial
- 1 May 2009
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 53 (5) , 856-865
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Interventions for preventing bone disease in kidney transplant recipientsCochrane Database of Systematic Reviews, 2007
- Use of Oral Corticosteroids and Risk of FracturesJournal of Bone and Mineral Research, 2005
- Long-term effects on bone mineral density of pamidronate given at the time of renal transplantationKidney International, 2003
- Alendronate Prevents Further Bone Loss in Renal Transplant RecipientsJournal of Bone and Mineral Research, 2001
- PREVENTION OF BONE LOSS WITH ALENDRONATE IN KIDNEY TRANSPLANT RECIPIENTSTransplantation, 2000
- Preventing bone loss after renal transplantation with bisphosphonates: We can… but should we?Kidney International, 2000
- Pamidronate therapy as prevention of bone loss following renal transplantationKidney International, 2000
- Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosisJournal of Bone and Mineral Research, 1996
- Post-transplantation bone disease: The role of immunosuppressive agents and the skeletonJournal of Bone and Mineral Research, 1996
- FACTORS INFLUENCING VERTEBRAL BONE DENSITY AFTER RENAL TRANSPLANTATIONTransplantation, 1994